Overactive bladder syndrome - management and treatment options
- PMID: 23145420
Overactive bladder syndrome - management and treatment options
Abstract
Background: Overactive bladder syndrome is a symptom-based clinical diagnosis. It is characterised by urinary urgency, frequency and nocturia, with or without urge urinary incontinence. These symptoms can often be managed in the primary care setting.
Objective: This article provides a review on overactive bladder syndrome and provides advice on management for the general practitioner.
Discussion: Overactive bladder syndrome can have a significant effect on quality of life, and affects 12-17% of the population. Prevalence increases with age. The management of overactive bladder syndrome involves exclusion of underlying pathology. First line treatment includes lifestyle interventions, pelvic floor exercises, bladder training and antimuscarinic agents. Failure of conservative management necessitates urology referral. Second line therapies are more invasive, and include botulinum toxin, neuromodulation or surgical interventions such as augmentation cystoplasty or urinary diversion.
Similar articles
-
An overview of treatment of overactive bladder syndrome in women.J Obstet Gynaecol. 2012 Apr;32(3):217-21. doi: 10.3109/01443615.2011.649317. J Obstet Gynaecol. 2012. PMID: 22369391 Review.
-
Management of overactive bladder syndrome.Postgrad Med J. 2007 Jul;83(981):481-6. doi: 10.1136/pgmj.2007.057232. Postgrad Med J. 2007. PMID: 17621619 Free PMC article. Review.
-
Overactive bladder: diagnosis and management.Maturitas. 2012 Feb;71(2):188-93. doi: 10.1016/j.maturitas.2011.11.016. Epub 2011 Dec 23. Maturitas. 2012. PMID: 22197347 Review.
-
Understanding clinic options for overactive bladder.Curr Urol Rep. 2013 Dec;14(6):541-8. doi: 10.1007/s11934-013-0353-6. Curr Urol Rep. 2013. PMID: 23812967 Review.
-
Overactive Bladder.Obstet Gynecol Clin North Am. 2016 Mar;43(1):59-68. doi: 10.1016/j.ogc.2015.10.002. Obstet Gynecol Clin North Am. 2016. PMID: 26880508 Review.
Cited by
-
Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study.Curr Med Res Opin. 2021 Aug;37(8):1303-1313. doi: 10.1080/03007995.2021.1920899. Epub 2021 May 13. Curr Med Res Opin. 2021. PMID: 33890538 Free PMC article.
-
Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder.Drugs Aging. 2016 Oct;33(10):755-763. doi: 10.1007/s40266-016-0399-5. Drugs Aging. 2016. PMID: 27681701
-
Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada.Can Urol Assoc J. 2017 Mar-Apr;11(3-4):123-130. doi: 10.5489/cuaj.4114. Can Urol Assoc J. 2017. PMID: 28515812 Free PMC article.
-
Personalised 3D-Printed Mucoadhesive Gastroretentive Hydrophilic Matrices for Managing Overactive Bladder (OAB).Pharmaceuticals (Basel). 2023 Feb 28;16(3):372. doi: 10.3390/ph16030372. Pharmaceuticals (Basel). 2023. PMID: 36986471 Free PMC article.
-
Variation in the Definitions of Urinary Retention in Studies of Intravesical Botulinum Toxin for Idiopathic Overactive Bladder: A Narrative Systematic Review.Neurourol Urodyn. 2025 Apr;44(4):860-877. doi: 10.1002/nau.70017. Epub 2025 Feb 17. Neurourol Urodyn. 2025. PMID: 39960111 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical